Your fact-checks will appear here
COVID-19 vaccination and its effects on myocarditis
High‑dose ivermectin studies in humans and pharmacovigilance analyses document a spectrum of neurologic events—from common, mild symptoms such as dizziness and somnolence observed in trials to rare bu...
Peer‑reviewed population studies and systematic reviews consistently show myocarditis after mRNA COVID‑19 vaccination is rare, concentrated among adolescent and young adult males—most commonly within ...
A single dose of the Novavax 2024–2025 formulation (JN.1-based) is authorized for use in vaccine‑naïve individuals ≥12 years in the United States, and regulatory documents describe a single‑dose regim...